Haha. What a joke! This company had preliminary results for hayfever that were looking O so positive. Suddenly, the truth seeped out like a poison after the final results were revealed. Even if this company did pass its OA trials, you probably won't see many physicians converting to treatment, unless there are substantial improvements in outcomes over the conventional therapies. A HARD TASK. Definitely hard to justify its current market cap with one indication fresh off the chopping block already.
DYOR and with common sense
Buckle Up, Toot Toot the Chart linked, page-5
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.055(20.4%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 33.5¢ | 27.5¢ | $1.328M | 4.323M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 152597 | 4 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
